Pure Global

Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation - Trial NCT00487656

Access comprehensive clinical trial information for NCT00487656 through Pure Global AI's free database. This Phase 2 trial is sponsored by Artisan Pharma, Inc. and is currently Completed. The study focuses on Sepsis,Disseminated Intravascular Coagulation. Target enrollment is 750 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT00487656
Phase 2
Completed
drug
Trial Details
ClinicalTrials.gov • NCT00487656
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation
A Randomized, Double-Blind, Placebo-Controlled, Phase-2B Study to Assess the Safety and Efficacy Effects of ART-123 on Subjects With Sepsis and Disseminated Intravascular Coagulation

Study Focus

ART-123

Interventional

drug

Sponsor & Location

Artisan Pharma, Inc.

Birmingham,Phoenix,Tuscon,Bakersfield,Colton,Loma Linda,Long Beach,Los Angeles,Rancho Mirage,San Diego,San Francisco,Stanford,Hartford,Bay Pines,Celebration,Jacksonville,Miami,Orlando,Atlanta,Augusta,, Canada,Malaysia,Thailand,United States of America

Timeline & Enrollment

Phase 2

Jul 01, 2007

Aug 01, 2010

750 participants

Primary Outcome

28-Day All-cause mortality

Summary

The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin)
 decreases the number of people who die as a result of Disseminated Intravascular Coagulation
 (DIC) complication of sepsis.

ICD-10 Classifications

Disseminated intravascular coagulation of fetus and newborn
Disseminated intravascular coagulation [defibrination syndrome]
Sepsis, unspecified
Other specified sepsis
Other sepsis

Data Source

ClinicalTrials.gov

NCT00487656

Non-Device Trial